Why is the Spire Healthcare share price up 25% today?

The Spire Healthcare share is a big gainer in today’s trading, but the question is whether it’s a good investment to make?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK-based hospital group Spire Healthcare (LSE: SPI) is one of the biggest FTSE gainers today. As I write, its share price is up 25% from yesterday’s close, the highest levels seen since August 2018.

Why has the share price risen?

The sharp upturn follows the proposed acquisition of the company by Australia’s Ramsay Health Care at an offer of 240p per share. To give some perspective, yesterday’s closing price was 193p. In today’s trading, the company’s share price has quickly risen beyond this offer price to 244p. 

If I were looking at these numbers today, it would make sense to buy the share at levels lower than the offer price, which could earn some assured returns in the foreseeable future.

What happens now 

However, that is only if the deal does go through. It may not. There are already reports that institutional shareholders are disappointed with the offer price. According to a Sky News report, they want to push the price up to 400p

If the two groups are in negotiations, then it is possible that the Spire Healthcare share price will rise even higher. But that is all just speculation. And at the Motley Fool, we believe in long-term investing. 

So, the company is of interest to me only if the deal does not go through and there is no more likelihood of a sell-out. To assess if it is indeed a stock I’d like to buy (or not), I looked at the financials first. 

Financials affected, but good outlook

The full-year 2020 was pretty bad for it as elective surgeries were suspended and its contracts with the NHS meant that all its capacity was made available to the service. As a result, its revenues declined by 6.2% from the year before and it ran up an operating loss of £146m. 

This is in sharp contrast to its growing revenue in 2019 and an operating profit of £94m. This, however, gives me hope that it can bounce back as the pandemic recedes. This hope is also bolstered by its performance in the second half of 2020, which showed a revenue increase of 5.9% from the year before.

Also, there are signs of healthy demand in 2021. For instance, its private enquiries are higher than in last year and there is a waiting list for private surgeries, among others.  

Reduced debt

Notably, Spire Healthcare’s net bank debt actually reduced during the year because of advance payments received on its NHS contracts, measured capital spending, and suspension of its final dividend. This is a particular positive in my view, at a time when companies have actually racked up debt

My takeaway

All of this matters, however, only if the company’s acquisition does not go through. For now, I think it is a good idea for me to wait and watch how things progress. If it does not, the Spire Healthcare share does merit consideration.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »